The impact of genomics on the exploitation of the myxobacterial secondary metabolome.
Pharmaceutical Biotechnology, Saarland University, 66041, Saarbrücken, Germany.
Silke C
SC
Wenzel
Rolf
R
Müller
D001688:Biological Products / Q000737:chemistry / Q000302:isolation & purification*; D023281:Genomics; D055442:Metabolome; D015394:Molecular Structure; D009231:Myxococcales / Q000235:genetics* / Q000378:metabolism*
D001688:Biological Products